Sorted by Authors

Publications - Sorted by Authors

• Spurny-Dworak B, Godbersen GM, Reed MB, Unterholzner J, Vanicek T, Baldinger-Melich P, Hahn A, Kranz GS, Bogner W, Lanzenberger R, Kasper S (2022) The impact of theta-burst stimulation on cortical GABA and glutamate in treatment-resistant depression: A surface-based MRSI analysis approach. Front Mol Neurosci, : 913274
  | Weblink |
• Komorowski A, Murgas M, Vidal R, Singh A, Gryglewski G, Kasper S, Wiltfang J, Lanzenberger R, Goya-Maldonado R (2022) Regional gene expression patterns are associated with task-specific brain activation during reward and emotion processing measured with functional MRI Human Brain Mapping, 43: 5266-5280
  | Weblink |
• Vanicek T, Unterholzner J, Lanzenberger R, Naderi-Heiden A, Kasper S, Praschak-Rieder N (2022) Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder World J Biol Psychiatry, 23 (9): 715-718
  | Weblink |

• Sauerzopf U, Weidenauer A, Dajic I, Bauer M, Bartova L, Meyer B, Nics L, Philippe C, Pfaff S, Pichler V, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R, Pezawas L, Praschak-Rieder N, Willeit M (2021) Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia Neuroimage Clin, 32: 102813
  | Weblink |
• Gryglewski G, Lanzenberger R, Silberbauer LR, Pacher D, Kasper S, Rupprecht R, Frey R, Baldinger-Melich P (2021) Meta-analysis of brain structural changes after electroconvulsive therapy in depression Brain Stimul, 14: 927-937
  | Weblink |
• Rütgen M, Pfabigan D, Tik M, Kraus C, Pletti C, Sladky R, Klöbl M, Woletz M, Vanicek T, Windischberger C, Lanzenberger R, Lamm C (2021) Detached empathic experience of others’ pain in remitted states of depression – An fMRI study Neuroimage Clin, 31: 102699
• Riederer F, Seiger R, Lanzenberger R, Pataraia E, Kasprian G, Michels L, Kollias S, Czech T, Hainfellner J, Beiersdorf J, Baumgartner C (2021) Automated volumetry of hippocampal subfields in temporal lobe epilepsy Epilepsy Res, 175: 106692
• Hahn A, Reed M, Pichler V, Michenthaler P, Rischka L, Godbersen G, Wadsak W, Hacker M, Lanzenberger R (2021) Functional dynamics of dopamine synthesis during monetary reward and punishment processing Cereb Blood Flow Metab, : 0271678X2110198
• Rischka L, Godbersen G, Pichler V, Michenthaler P, Klug S, Klöbl M, Ritter V, Wadsak W, Hacker M, Kasper S, Lanzenberger R, Hahn A (2021) Reliability of task-specific neuronal activation assessed with functional PET, ASL and BOLD imaging Cereb Blood Flow Metab, : 0271678X2110205
  | Weblink |
• Höflich A, Kraus C, Pfeiffer R, Seiger R, Rujescu D, Zarate C, Kasper S, Winkler D, Lanzenberger R (2021) Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial Transl Psychiat, 11 (1): 200
  | Weblink |
• Seiger R, Gryglewski G, Klöbl M, Kautzky A, Godbersen G, Rischka L, Vanicek T, Hienert M, Unterholzner J, Silberbauer L, Michenthaler P, Handschuh P, Hahn A, Kasper S, Lanzenberger R (2021) The influence of acute SSRI administration on white matter microstructure in patients suffering from major depressive disorder and healthy controls Int J Neuropsychopharmacol, 24 (7): 542-550
  | Weblink |

• Dajić I, Praschak-Rieder N, Lanzenberger R, Spindelegger C, Kasper S, Willeit M (2021) Neuroimaging in Seasons and Winter Depression. In: Rudi A.J.O. Dierckx, Andreas Otte, Erik F. J. de Vries, Aren van Waarde, Iris E. Sommer, PET and SPECT in Psychiatry, Vol.2 Springer International Publishing: 245-259
  | Weblink |

• Calabrò M, Porcelli S, Crisafulli C, Albani D, Kasper S, Zohar J, Souery D, Montgomery S, Mantovani V, Mendlewicz J, Bonassi S, Vieta E, Frustaci A, Ducci G, Landi S, Boccia S, Bellomo A, Di Nicola M, Janiri L, Colombo R, Mandelli L, Fabbri C, Serretti A (2020) Genetic variants associated with psychotic symptoms across disorders psychotic symptoms. Neurosci Lett, 720: 134754
  | Weblink |
• Spurny B, Seiger R, Moser P, Vanicek T, Reed M, Heckova E, Michenthaler P, Basaran A, Gryglewski G, Klöbl M, Trattnig S, Kasper S, Bogner W, Lanzenberger R (2020) Hippocampal GABA levels correlate with retrieval performance in an associative learning paradigm Neuroimage, 204: 116244
  | Weblink |
• Gryglewski G, Seiger R, Baldinger-Melich P, Unterholzner J, Spurny B, Vanicek T, Hahn, Kasper S, Frey R, Lanzenberger R (2020) Changes in white matter microstructure after electroconvulsive therapy in treatment resistant depression Int J Neuropsychopharmacol, 23: 20-25
  | Weblink |
• Shiyam Sundar L, Iommi D, Muzik O, Chalampalakis Z, Klebermass E, Hienert M, Rischka L, Lanzenberger R, Hahn A, Pataraia E, Traub-Weidinger T, Hummel J, Beyer T (2020) Conditional Generative Adversarial Networks Aided Motion Correction of Dynamic 18F-FDG PET Brain Studies J Nucl Med, 62 (6): 871-879
• Kraus C, Kadriu B, Lanzenberger R, Zarate C, Kasper S (2020) Prognosis and Improved Outcomes in Major Depression: A Review Focus, 18 (2): 220-235
  | Weblink |
• Kraus C, Hahn A, Sigurdardottir H, Spurny B, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R (2020) Brain glucose uptake during transcranial direct current stimulation measured with functional [18F]FDG-PET Brain Imaging Behav, 14 (2): 477-484
  | Weblink |
• Pjrek E, Friedrich M, Cambioli L, Dold M, Jäger F, Komorowski A, Lanzenberger R, Kasper S, Winkler D (2020) The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials Psychother Psychosom, 89 (1): 17-24
  | Weblink |
• Komorowski A, Weidenauer A, Murgaš M, Sauerzopf U, Wadsak W, Mitterhauser M, Bauer M, Hacker M, Praschak-Rieder N, Kasper S, Lanzenberger R, Willeit M (2020) Association of dopamine D2/3 receptor binding potential measured using PET and [11C]-(+)-PHNO with post-mortem DRD2/3 gene expression in the human brain Neuroimage, 223: 117270
  | Weblink |
• Unterholzner J, Gryglewski G, Philippe C, Seiger R, Pichler V, Godbersen G, Berroterán-Infante N, Murgaš M, Hahn A, Wadsak W, Mitterhauser M, Kasper S, Lanzenberger R (2020) Topologically Guided Prioritization of Candidate Gene Transcripts Coexpressed with the 5-HT1A Receptor by Combining In Vivo PET and Allen Human Brain Atlas Data Cereb. Cortex, 30 (6): 3771-3780
  | Weblink |
• Kautzky A, Vanicek T, Philippe C, Kranz G, Wadsak W, Mitterhauser M, Hartmann A, Hahn A, Hacker M, Rujescu D, Kasper S, Lanzenberger R (2020) Machine learning classification of ADHD and HC by multimodal serotonergic data Transl Psychiat, 10: 104
  | Weblink |
• Silberbauer L, Bartova L, Papageorgiou K, Lanzenberger R, Kasper S, Winkler D (2020) Oral Ketamine as a Treatment Option in Patients With Treatment Resistant Depression and Comorbid Arterial Hypertension J Clin Psychopharmacol, 40 (4): 418-420
• Hahn A, Breakspear M, Rischka L, Wadsak W, Godbersen G, Pichler V, Michenthaler P, Vanicek T, Hacker M, Kasper S, Lanzenberger R, Cocchi L (2020) Reconfiguration of functional brain networks and metabolic cost converge during task performance eLife, 9: e52443
  | Weblink |
• Spurny B, Seiger R, Moser P, Vanicek T, Reed M, Heckova E, Michenthaler P, Basaran A, Gryglewski G, Klöbl M, Trattnig S, Kasper S, Bogner W, Lanzenberger R (2020) Hippocampal GABA levels correlate with retrieval performance in an associative learning paradigm Neuroimage, 204: 116244
  | Weblink |
• Klöbl M, Gryglewski G, Rischka L, Godbersen G, Unterholzner J, Reed M, Michenthaler P, Vanicek T, Winkler-Pjrek E, Hahn A, Kasper S, Lanzenberger R (2020) Predicting Antidepressant Citalopram Treatment Response via Changes in Brain Functional Connectivity After Acute Intravenous Challenge Front Comput Neurosci, 14: 554186
  | Weblink |
• Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer B, Rabl U, Sezen P, Cumming P, Stimpfl T, Sitte H, Lanzenberger R, Mossaheb N, Zimprich A, Rusjan P, Dorffner G, Mitterhauser M, Hacker M, Pezawas L, Kasper S, Wadsak W, Praschak-Rieder N, Willeit M (2020) On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study Transl Psychiat, 10 (2): 2
  | Weblink |
• Baldinger-Melich P, Urquijo Castro M, Seiger R, Ruef A, Dwyer D, Kranz G, Klöbl M, Kambeitz J, Kaufmann U, Windischberger C, Kasper S, Falkai P, Lanzenberger R, Koutsouleris N (2020) Sex Matters: A Multivariate Pattern Analysis of Sex- and Gender-Related Neuroanatomical Differences in Cis- and Transgender Individuals Using Structural Magnetic Resonance Imaging Cereb. Cortex, 30 (3): 1345-1356
  | Weblink |

• Silberbauer L, James G, Spies M, Michenthaler P, Kranz GS, Kasper S, Lanzenberger R (2020) Molecular neuroimaging of the serotonergic system with PET. In: , Handbook of the Behavioral Neurobiology of Serotonin Elsevier: 175-194

• Rütgen M, Pletti C, Tik M, Kraus C, Pfabigan D, Sladky R, Klöbl M, Woletz M, Vanicek T, Windischberger C, Lanzenberger R, Lamm C (2019) Antidepressant treatment, not depression, leads to reductions in behavioral and neural responses to pain empathy Transl Psychiat, 9 (1)
• Rischka L, Gryglewski G, Berroterán-Infante N, Rausch I, James G, Klöbl M, Sigurdardottir H, Hartenbach M, Hahn A, Wadsak W, Mitterhauser M, Beyer T, Kasper S, Prayer D, Hacker M, Lanzenberger R (2019) Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI Front Physiol, 10: 1422
  | Weblink |
• Gryglewski G, Seiger R, Baldinger-Melich P, Unterholzner J, Spurny B, Vanicek T, Hahn A, Kasper S, Frey R, Lanzenberger R (2019) Changes in White Matter Microstructure After Electroconvulsive Therapy for Treatment-Resistant Depression Int J Neuropsychopharmacol, 23 (1): 20-25
  | Weblink |
• Spies M, Klöbl M, Höflich A, Hummer A, Vanicek T, Michenthaler P, Kranz G, Hahn A, Winkler D, Windischberger C, Kasper S, Lanzenberger R (2019) Association between dynamic resting-state functional connectivity and ketamine plasma levels in visual processing networks Sci Rep, 9 (1): 11484
  | Weblink |
• Sigurdardottir H, Kranz G, Rami-Mark C, James G, Vanicek T, Gryglewski G, Berroterán-Infante N, Kautzky A, Hienert M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hartmann A, Hacker M, Rujescu D, Kasper S, Lanzenberger R (2019) Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity–impulsivity symptoms in ADHD measured with PET Mol Psychiatry,
  | Weblink |
• Mori A, Klöbl M, Okada G, Reed M, Takamura M, Michenthaler P, Takagaki K, Handschuh P, Yokoyama S, Murgas M, Ichikawa N, Gryglewski G, Shibasaki C, Spies M, Yoshino A, Hahn A, Okamoto Y, Lanzenberger R, Yamawaki S, Kasper S (2019) Predicting Ventral Striatal Activation During Reward Anticipation From Functional Connectivity at Rest Front Hum Neurosci, 13: 289
  | Weblink |
• Kraus C, Seiger R, Pfabigan D, Sladky R, Tik M, Paul K, Woletz M, Gryglewski G, Vanicek T, Komorowski A, Kasper S, Lamm C, Windischberger C, Lanzenberger R (2019) Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study Int J Neuropsychopharmacol, 22 (8): 513-522
  | Weblink |
• Silberbauer L, Gryglewski G, Berroterán-Infante N, Rischka L, Vanicek T, Pichler V, Hienert M, Kautzky A, Philippe C, Godbersen G, Vraka C, James G, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Hahn A, Lanzenberger R (2019) Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MR Front Mol Neurosci, 12: 172
  | Weblink |
• Vanicek T, Kranz G, Vyssoki B, Komorowski A, Fugger G, Höflich A, Micskei Z, Milovic S, Lanzenberger R, Eckert A, Kasper S, Frey R (2019) Repetitive Enhancement of Serum BDNF Subsequent to Continuation ECT Acta Psychiatr Scand, 140 (5): 426-434
  | Weblink |
• Gryglewski G, Klöbl M, Berroterán-Infante N, Rischka L, Balber T, Vanicek T, Pichler V, Kautzky A, Klebermass E, Reed M, Vraka C, Hienert M, James G, Silberbauer L, Godbersen G, Unterholzner J, Michenthaler P, Hartenbach M, Winkler-Pjrek E, Wadsak W, Mitterhauser M, Hahn A, Hacker M, Kasper S, Lanzenberger R (2019) Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging Eur Neuropsychopharmacol, 29 (6): 711-719
  | Weblink |
• Vanicek T, Kranz G, Vyssoki B, Fugger G, Komorowski A, Höflich A, Saumer G, Milovic S, Lanzenberger R, Eckert A, Kasper S, Frey R (2019) Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression Brain Stimul, 12 (4): 1041-1050
  | Weblink |
• Tik M, Woletz M, Kranz G, Pfabigan D, Geissberger N, Sladky R, Kraus C, Auer B, Vanicek T, Paul K, Lanzenberger R, Lamm C, Windischberger C (2019) Remission from depression and tms over left DLPFC share the same network connectivity changes Brain Stimul, 12 (2): 435-436
  | Supplement |
• Baldinger-Melich P, Gryglewski G, Philippe C, James G, Vraka C, Silberbauer L, Balber T, Vanicek T, Pichler V, Unterholzner J, Kranz G, Hahn A, Winkler D, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Frey R, Lanzenberger R (2019) The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography Brain Stimul, 12 (3): 714-723
  | Weblink |
• Kautzky A, James G, Philippe C, Baldinger-Melich P, Kraus C, Kranz G, Vanicek T, Gryglewski G, Hartmann A, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R (2019) Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression Transl Psychiat, 9 (1): 5
  | Weblink |
• Hahn A, Lanzenberger R, Kasper S (2019) Making Sense of Connectivity Int J Neuropsychopharmacol, 22 (3): 194-207
  | Weblink |
• Gryglewski G, Baldinger-Melich P, Seiger R, Godbersen G, Michenthaler P, Klöbl M, Spurny B, Kautzky A, Vanicek T, Kasper S, Frey R, Lanzenberger R (2019) Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis Br J Psychiatry, 214: 159-167
  | Weblink |
• James G, Gryglewski G, Vanicek T, Berroterán-Infante N, Philippe C, Kautzky A, Nics L, Vraka C, Godbersen G, Unterholzner J, Sigurdardottir H, Spies M, Seiger R, Kranz G, Hahn A, Mitterhauser M, Wadsak W, Bauer A, Hacker M, Kasper S, Lanzenberger R (2019) Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivo Cereb. Cortex, 29: 372-382
  | Weblink |
• Kautzky A, Dold M, Bartova L, Spies M, Kranz G, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Dikeos D, Rujescu D, Kasper S (2019) Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study Acta Psychiatr Scand, 139 (1): 78-88
  | Weblink |
• Höflich A, Michenthaler P, Kasper S, Lanzenberger R (2019) Circuit mechanisms of reward, anhedonia and depression Int J Neuropsychopharmacol, 22 (2): 105-118
  | Weblink |

• Hienert M, Ritter P, Bauer M, Lanzenberger R, Kasper S (2019) Die klinische Anwendung von Milnacipran in Österreich und Deutschland Nervenheilkunde, 38 (04): 178-183
  | Weblink |
• Komorowski A, Kautzky A, Vanicek T, Lanzenberger R, Kasper S (2019) Hirnbildgebung im forensischen Kontext – Möglichkeiten und Grenzen Journal für Neurologie, Neurochirurgie und Psychiatrie, 20: 25-33

• Kautzky A, Lanzenberger R, Kasper S (2019) Big Data Guided Interventions: Predicting Treatment Response. In: Passos IC, Mwangi B, Kapczinski F, Personalized Psychiatry - Big Data Analytics in Mental Health Springer International Publishing: 53-76
  | Weblink |
• Kraus C, Lanzenberger R, Kasper S (2019) Neurobiologische Erklärungsmodelle. . In: Bundesministerium für Arbeit, Soziales, Gesundheit und Konsumentenschutz., Depressionsbericht Österreich. Eine interdisziplinäre und multiperspektivische Bestandsaufnahme. Bundesministerium für Arbeit, Soziales, Gesundheit und Konsumentenschutz.: 64-69

• Woletz M, Hoffmann A, Tik M, Sladky R, Lanzenberger R, Robinson S, Windischberger C (2018) Beware detrending: Optimal preprocessing pipeline for low-frequency fluctuation analysis Human Brain Mapping, 40 (5): 1571-1582
• Kraus C, Klöbl M, Tik M, Auer B, Vanicek T, Geissberger N, Pfabigan D, Hahn A, Woletz M, Paul K, Komorowski A, Kasper S, Windischberger C, Lamm C, Lanzenberger R (2018) The pulvinar nucleus and antidepressant treatment: dynamic modeling of antidepressant response and remission with ultra-high field functional MRI Mol Psychiatry, 24 (5): 746-756
  | Weblink |
• Kautzky A, Seiger R, Hahn A, Fischer P, Krampla W, Kasper S, Kovacs G, Lanzenberger R (2018) Prediction of Autopsy Verified Neuropathological Change of Alzheimer’s Disease Using Machine Learning and MRI Front Aging Neurosci, 10: 406
  | Weblink |
• Gryglewski G, Seiger R, James G, Godbersen G, Komorowski A, Unterholzner J, Michenthaler P, Hahn A, Wadsak W, Mitterhauser M, Kasper S, Lanzenberger R (2018) Corrigendum to “Spatial analysis and high resolution mapping of the human whole-brain transcriptome for integrative analysis in neuroimaging” Neuroimage,
  | Weblink |
• Spies M, James G, Vraka C, Philippe C, Hienert M, Gryglewski G, Komorowski A, Kautzky A, Silberbauer L, Pichler V, Kranz G, Nics L, Balber T, Baldinger-Melich P, Vanicek T, Spurny B, Winkler-Pjrek E, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R, Winkler D (2018) Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy Transl Psychiat, 8 (1): 198
  | Weblink |
• Hienert M, Gryglewski G, Stamenkovic M, Kasper S, Lanzenberger R (2018) Striatal dopaminergic alterations in Tourette’s syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies Transl Psychiat, 8 (1): 143
  | Weblink |
• Rischka L, Gryglewski G, Pfaff S, Vanicek T, Hienert M, Klöbl M, Hartenbach M, Haug A, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R, Hahn A (2018) Reduced task durations in functional PET imaging with [ 18 F]FDG approaching that of functional MRI Neuroimage, 181: 323-330
  | Weblink |
• Gryglewski G, Seiger R, James G, Godbersen G, Komorowski A, Unterholzner J, Michenthaler P, Hahn A, Wadsak W, Mitterhauser M, Kasper S, Lanzenberger R (2018) Spatial analysis and high resolution mapping of the human whole-brain transcriptome for integrative analysis in neuroimaging Neuroimage, 176: 259-267
  | Weblink |
• Kraus C, Vanicek T, Weidenauer A, Khanaqa T, Stamenkovic M, Lanzenberger R, Willeit M, Kasper S (2018) DiGeorge syndrome Wien. Klin. Wochenschr., 130 (7-8): 283-287
  | Weblink |
• Kautzky A, Dold M, Bartova L, Spies M, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Kasper S (2018) Refining Prediction in Treatment-Resistant Depression J Clin Psychiatry, 79 (1): 16m11385
  | Weblink |
• Kranz G, Hahn A, Kraus C, Spies M, Pichler V, Jungwirth J, Mitterhauser M, Wadsak W, Windischberger C, Kasper S, Lanzenberger R (2018) Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers Neuroimage, 171: 1-5
  | Weblink |
• Spies M, James G, Berroterán-Infante N, Ibeschitz H, Kranz G, Unterholzner J, Godbersen M, Gryglewski G, Hienert M, Jungwirth J, Pichler V, Reiter B, Silberbauer L, Winkler D, Mitterhauser M, Stimpfl T, Hacker M, Kasper S, Lanzenberger R (2018) Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography Int J Neuropsychopharmacol, 21 (2): 145-153
  | Weblink |
• Kranz G, Hahn A, Kaufmann U, Tik M, Ganger S, Seiger R, Hummer A, Windischberger C, Kasper S, Lanzenberger R (2018) Effects of testosterone treatment on hypothalamic neuroplasticity in female-to-male transgender individuals Brain Struct Funct, 223 (1): 321-328
  | Weblink |

• Hahn A, Gryglewski G, Nics L, Rischka L, Ganger S, Sigurdardottir H, Vraka C, Silberbauer L, Vanicek T, Kautzky A, Wadsak W, Mitterhauser M, Hartenbach M, Hacker M, Kasper S, Lanzenberger R (2017) Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity Brain Struct Funct, 223: 1369-1378
  | Weblink |
• Kautzky A, James G, Philippe C, Baldinger-Melich P, Kraus C, Kranz G, Vanicek T, Gryglewski G, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R (2017) The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning Transl Psychiat, 7 (6): e1150
  | Weblink |
• Kraus C, Castrén E, Kasper S, Lanzenberger R (2017) Serotonin and Neuroplasticity – Links between molecular, functional and structural pathophysiology in depression Neurosci Biobehav R, 77: 317-326
  | Weblink |
• Kranz G, Seiger R, Kaufmann U, Hummer A, Hahn A, Ganger S, Tik M, Windischberger C, Kasper S, Lanzenberger R (2017) Effects of sex hormone treatment on white matter microstructure in individuals with gender dysphoria Neuroimage, 150: 60-67
  | Weblink |
• James G, Baldinger-Melich P, Philippe C, Kranz G, Vanicek T, Hahn A, Gryglewski G, Hienert M, Spies M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R (2017) Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression Front Hum Neurosci, 11: 48
  | Weblink |
• Kautzky A, Baldinger-Melich P, Kranz G, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Serretti A, Lanzenberger R, Kasper S (2017) A New Prediction Model for Evaluating Treatment-Resistant Depression J Clin Psychiatry, 78: 215-222
  | Weblink |
• Kraus C, Rabl U, Vanicek T, Carlberg L, Popovic A, Spies M, Bartova L, Gryglewski G, Papageorgiou K, Lanzenberger R, Willeit M, Winkler D, Rybakowski J, Kasper S (2017) Administration of ketamine for unipolar and bipolar depression Int J Psychiatry Clin Pract, 21: 2-12
  | Weblink |
• Spies M, Kraus C, Geissberger N, Auer B, Klöbl M, Tik M, Stürkat I, Hahn A, Woletz M, Pfabigan D, Kasper S, Lamm C, Windischberger C, Lanzenberger R (2017) Default mode network deactivation during emotion processing predicts early antidepressant response Transl Psychiatry, 7 (1): e1008
  | Weblink |
• Gryglewski G, Rischka L, Philippe C, Hahn A, James G, Klebermass E, Hienert M, Silberbauer L, Vanicek T, Kautzky A, Berroterán-Infante N, Nics L, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R (2017) Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion Neuroimage, 149: 23-32
  | Weblink |
• Höflich A, Ganger S, Tik M, Hahn A, Kranz G, Vanicek T, Spies M, Kraus C, Windischberger C, Kasper S, Winkler D, Lanzenberger R (2017) Imaging the neuroplastic effects of ketamine with VBM and the necessity of placebo control Neuroimage, 147: 198-203
  | Weblink |
• Komorowski A, James GM, Philippe C, Gryglewski G, Bauer A, Hienert M, Spies M, Kautzky A, Vanicek T, Hahn A, Traub-Weidinger T, Winkler D, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger (2017) Association of protein distribution and gene expression revealed by PET and post-mortem quantification in the serotonergic system of the human brain Cereb. Cortex, 27: 117-130
  | Weblink |
• Winkler D, Pjrek E, Spies M, Willeit M, Dorffner G, Lanzenberger R, Kasper S (2017) Has the existence of seasonal affective disorder been disproven? J Affect Disord, 208: 54-55
  | Weblink |
• Vanicek T, Kutzelnigg A, Philippe C, Sigurdardottir H, James G, Hahn A, Kranz G, Höflich A, Kautzky A, Traub-Weidinger T, Hacker M, Wadsak W, Mitterhauser M, Kasper S, Lanzenberger R (2017) Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET Human Brain Mapping, 38 (2): 792-802
  | Weblink |
• Höflich A, Hahn A, Küblböck M, Kranz G, Vanicek T, Ganger S, Spies M, Windischberger C, Kasper S, Winkler D, Lanzenberger R (2017) Ketamine-dependent neuronal activation in healthy volunteers Brain Struct Funct, 222 (3): 1533-1542
  | Weblink |

• Kraus C, Lanzenberger R, Kasper S (2017) Ketamine for the Treatment of Depression JAMA Psychiatry, 74 (9): 970
  | Weblink |

• Hahn A, Schain M, Erlandsson M, Sjölin P, James G, Strandberg O, Hägerström D, Lanzenberger R, Jögi J, Olsson T, Smith R, Hansson O (2016) Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology J Nucl Med, 58 (4): 623-631
• Seiger R, Hahn A, Hummer A, Kranz G, Ganger S, Woletz M, Kraus C, Sladky R, Kautzky A, Kasper S, Windischberger C, Lanzenberger R (2016) Subcortical gray matter changes in transgender subjects after long-term cross-sex hormone administration Psychoneuroendocrinology, 74: 371-379
  | Weblink |
• Hahn A, Gryglewski G, Nics L, Hienert M, Rischka L, Vraka C, Sigurdardottir H, Vanicek T, James G, Seiger R, Kautzky A, Silberbauer L, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R (2016) Quantification of task-specific glucose metabolism with constant infusion of 18F-FDG J Nucl Med, 57 (12): 1933-1940
  | Weblink |
• Schmitt A, Rujescu D, Gawlik M, Hasan A, Hashimoto K, Iceta S, Jarema M, Kambeitz J, Kasper S, Keeser D, Kornhuber J, Koutsouleris N, Lanzenberger R, Malchow B, Saoud M, Spies M, Stöber G, Thibaut F, Riederer P, Falkai P (2016) Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics World J Biol Psychiat, 17 (6): 406-428
  | Weblink |
• Kranz GS, Lanzenberger R, Kasper S (2016) Hat Testosteron einen stimmungsaufhellenden Effekt? Ärzte Woche, 1-2:18
• Baldinger-Melich P, Kraus C, Hahn A, Lanzenberger R, Kasper S (2016) Zerebrale Bildgebung bei affektiven Störungen und Angsterkrankungen Journal für Neurologie, Neurochirurgie und Psychiatrie, 17 (1): 16-20
• Baldinger-Melich P, Fugger G, Kraus C, Lanzenberger R, Popp W, Kasper S, Frey R (2016) Treatment-resistant Catatonia - A Case Report Clinical Neuropsychiatry, 13: 24-27
• Spies M, Hahn A, Kranz G, Sladky R, Kaufmann U, Hummer A, Ganger S, Kraus C, Winkler D, Seiger R, Comasco E, Windischberger C, Kasper S, Lanzenberger R (2016) Gender transition affects neural correlates of empathy: A resting state functional connectivity study with ultra high-field 7T MR imaging Neuroimage, 138: 257-265
  | Weblink |
• Hahn A, Kranz G, Sladky R, Kaufmann U, Ganger S, Hummer A, Seiger R, Spies M, Vanicek T, Winkler D, Kasper S, Windischberger C, Swaab D, Lanzenberger R (2016) Testosterone affects language areas of the adult human brain Human Brain Mapping, 37 (5): 1738-1748
  | Weblink |
• Sigurdardottir H, Kranz G, Rami-Mark C, James G, Vanicek T, Gryglewski G, Kautzky A, Hienert M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Rujescu D, Kasper S, Lanzenberger R (2016) Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET Human Brain Mapping, 37 (3): 884-895
  | Weblink |

• Ganger S, Hahn A, Küblböck M, Kranz G, Spies M, Vanicek T, Seiger R, Sladky R, Windischberger C, Kasper S, Lanzenberger R (2015) Comparison of continuously acquired resting state and extracted analogues from active tasks Human Brain Mapping, 36 (10): 4053-4063
• Rami-Mark C, Berroterán-Infante N, Philippe C, Foltin S, Vraka C, Hoepping A, Lanzenberger R, Hacker M, Mitterhauser M, Wadsak W (2015) Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [11C]ME@HAPTHI EJNMMI Res, 5 (1)
• Dold M, Fugger G, Aigner M, Lanzenberger R, Kasper S (2015) Dose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials Schizophr Res, 166 (1-3): 187-193
• Dold M, Aigner M, Lanzenberger R, Kasper S (2015) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials Int J Neuropsychopharmacol,
• Hoflich A, Hahn A, Kublbock M, Kranz G, Vanicek T, Windischberger C, Saria A, Kasper S, Winkler D, Lanzenberger R (2015) Ketamine-induced modulation of the thalamo-cortical network in healthy volunteers as a model for schizophrenia Int J Neuropsychopharmacol,
• Seiger R, Hahn A, Hummer A, Kranz GS, Ganger S, Küblböck M, Kraus C, Sladky R, Kasper S, Windischberger C, Lanzenberger R (2015) Voxel-based morphometry at ultra-high fields. A comparison of 7 T and 3 T MRI data Neuroimage, 113: 207-216
• Kautzky A, Baldinger P, Souery D, Montgomery S, Mendlewicz J, Zohar J, Serretti A, Lanzenberger R, Kasper S (2015) The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression Eur Neuropsychopharmacol, 25 (4): 441-453
• Fuchs I, Ansorge U, Huber-Huber C, Höflich A, Lanzenberger R (2015) S-ketamine influences strategic allocation of attention but not exogenous capture of attention Conscious Cogn,
• Haeusler D, Kuntner C, Nics L, Savli M, Zeilinger M, Wanek T, Karagiannis P, Lanzenberger R, Langer O, Shanab K, Spreitzer H, Wadsak W, Hacker M, Mitterhauser M (2015) [18F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodents Eur J Nucl Med Mol Imaging,
• Baldinger P, Kraus C, Rami-Mark C, Gryglewski G, Kranz G, Haeusler D, Hahn A, Spies M, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R (2015) Interaction between 5-HTTLPR and 5-HT1B genotype status enhances cerebral 5-HT1A receptor binding Neuroimage, 111: 505-512
• Philippe C, Zeilinger M, Mitterhauser M, Dumanic M, Lanzenberger R, Hacker M, Wadsak W (2015) Parameter evaluation and fully-automated radiosynthesis of [11C]harmine for imaging of MAO-A for clinical trials Appl Radiat Isot, 97: 182-187
• Pfabigan D, Seidel E, Paul K, Grahl A, Sailer U, Lanzenberger R, Windischberger C, Lamm C (2015) Context-sensitivity of the feedback-related negativity for zero-value feedback outcomes Biol Psychol, 104: 184-192
• Sladky R, Spies M, Hoffmann A, Kranz G, Hummer A, Gryglewski G, Lanzenberger R, Windischberger C, Kasper S (2015) (S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled double-blind fMRI study using dynamic causal modeling Neuroimage, 113: 207-216
• Hahn A, Kranz G, Sladky R, Ganger S, Windischberger C, Kasper S, Lanzenberger R (2015) Individual diversity of functional brain network economy Brain Connect, 5 (3): 156-165

• Spies M, Knudsen G, Lanzenberger R, Kasper S (2015) The serotonin transporter in psychiatric disorders: insights from PET imaging Lancet Psychiatry, 2 (8): 743-755

• Baldinger P, Höflich AS, Mitterhauser M, Hahn A, Rami-Mark C, Spies M, Wadsak W, Lanzenberger R, Kasper S (2014) Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging. Int. J. Neuropsychopharmacol.,
• Kranz G, Wadsak W, Kaufmann U, Savli M, Baldinger P, Gryglewski G, Haeusler D, Spies M, Mitterhauser M, Kasper S, Lanzenberger R (2014) High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People Biol Psychiatry,
• Kranz G, Hahn A, Kaufmann U, Kublbock M, Hummer A, Ganger S, Seiger R, Winkler D, Swaab D, Windischberger C, Kasper S, Lanzenberger R (2014) White Matter Microstructure in Transsexuals and Controls Investigated by Diffusion Tensor Imaging J Neurosci, 34 (46): 15466-15475
• Vanicek T, Spies M, Rami-Mark C, Savli M, Höflich A, Kranz G, Hahn A, Kutzelnigg A, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Volkow N, Kasper S, Lanzenberger R (2014) The Norepinephrine Transporter in Attention-Deficit/Hyperactivity Disorder Investigated With Positron Emission Tomography JAMA Psychiatry, 71 (12): 1340-1349
• Seidel E, Pfabigan D, Hahn A, Sladky R, Grahl A, Paul K, Kraus C, Küblböck M, Kranz G, Hummer A, Lanzenberger R, Windischberger C, Lamm C (2014) Uncertainty during pain anticipation: The adaptive value of preparatory processes Human Brain Mapping,
• Küblböck M, Woletz M, Höflich A, Sladky R, Kranz G, Hoffmann A, Lanzenberger R, Windischberger C (2014) Stability of low-frequency fluctuation amplitudes in prolonged resting-state fMRI Neuroimage, 103: 249-257
• Hahn A, Kranz G, Küblböck M, Kaufmann U, Ganger S, Hummer A, Seiger R, Spies M, Winkler D, Kasper S, Windischberger C, Swaab D, Lanzenberger R (2014) Structural Connectivity Networks of Transgender People Cereb. Cortex,
• Kraus C, Baldinger P, Rami-Mark C, Gryglewski G, Kranz G, Haeusler D, Hahn A, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R (2014) Exploring the Impact of BDNF Val66Met Genotype on Serotonin Transporter and Serotonin-1A Receptor Binding PLoS One, 9 (9): e106810
• Kranz G, Hahn A, Baldinger P, Haeusler D, Philippe C, Kaufmann U, Wadsak W, Savli M, Hoeflich A, Kraus C, Vanicek T, Mitterhauser M, Kasper S, Lanzenberger R (2014) Cerebral serotonin transporter asymmetry in females, males and male-to-female transsexuals measured by PET in vivo Brain Struct Funct, 219 (1): 171-183
• Kraus C, Ganger S, Losak J, Hahn A, Savli M, Kranz G, Baldinger P, Windischberger C, Kasper S, Lanzenberger R (2014) Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake Neuroimage, 84: 236-244
• Baldinger P, Kranz G, Haeusler D, Savli M, Spies M, Philippe C, Hahn A, Höflich A, Wadsak W, Mitterhauser M, Lanzenberger R, Kasper S (2014) Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET Neuroimage, 88: 252-262
• Hahn A, Haeusler D, Kraus C, Höflich A, Kranz G, Baldinger P, Savli M, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R (2014) Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression Human Brain Mapping, 35 (8): 3857-3866
• Comasco E, Hahn A, Ganger S, Gingnell M, Bannbers E, Oreland L, Wikström J, Epperson C, Lanzenberger R, Sundström-Poromaa I (2014) Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder Human Brain Mapping, 35 (9): 4450-4458
• Scharinger C, Rabl U, Kasess C, Meyer B, Hofmaier T, Diers K, Bartova L, Pail G, Huf W, Uzelac Z, Hartinger B, Kalcher K, Perkmann T, Haslacher H, Meyer-Lindenberg A, Kasper S, Freissmuth M, Windischberger C, Willeit M, Lanzenberger R, Esterbauer H ,Brocke B, Moser E, Sitte H, Pezawas L (2014) Platelet Serotonin Transporter Function Predicts Default-Mode Network Activity PLoS One, 9 (3): e92543
• Fabbri C, Marsano A, Albani D, Chierchia A, Calati R, Drago A, Crisafulli C, Calabrò M, Kasper S, Lanzenberger R, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A (2014) PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway Pharmacogenomics J, 14 (5): 463-472
• Pfabigan D, Seidel E, Sladky R, Hahn A, Paul K, Grahl A, Küblböck M, Kraus C, Hummer A, Kranz G, Windischberger C, Lanzenberger R, Lamm C (2014) P300 amplitude variation is related to ventral striatum BOLD response during gain and loss anticipation: An EEG and fMRI experiment Neuroimage, 96: 12-21
• Gryglewski G, Lanzenberger R, Kranz G, Cumming P (2014) Meta-analysis of molecular imaging of serotonin transporters in major depression J Cereb Blood Flow Metab, 34 (7): 1096-1103
• Baldinger P, Lotan A, Frey R, Kasper S, Lerer B, Lanzenberger R (2014) Neurotransmitters and Electroconvulsive Therapy J ECT, 30 (2): 116-121
• Kranz G, Rami-Mark C, Kaufmann U, Baldinger P, Hahn A, Höflich A, Savli M, Stein P, Wadsak W, Mitterhauser M, Winkler D, Lanzenberger R, Kasper S (2014) Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-11C]WAY-100635 Psychoneuroendocrinology, 45: 1-10
• Stein P, Baldinger P, Kaufmann U, Christina R, Hahn A, Höflich A, Kranz G, Savli M, Wadsak W, Mitterhauser M, Winkler D, Kasper S, Lanzenberger R (2014) Relation of progesterone and DHEAS serum levels to 5-HT1A receptor binding potential in pre- and postmenopausal women Psychoneuroendocrinology, 46: 52-63
• Winkler D, Pjrek E, Lanzenberger R, Baldinger P, Eitel D, Kasper S, Frey R (2014) Actigraphy in patients with treatment-resistant depression undergoing electroconvulsive therapy J Psychiatr Res, 57: 96-100
• Kasper S, Kranz G, Lanzenberger R (2014) Testosterone, Neural Circuits, and Male Depression Biol Psychiatry, 76 (4): 272-273

• Kasper S, Gryglewski G, Lanzenberger R (2014) Imaging brain circuits in anxiety disorders Lancet Psychiatry, 1 (4): 251-252
• Toffoletto S, Lanzenberger R, Gingnell M, Sundström-Poromaa I, Comasco E (2014) Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: A systematic review Psychoneuroendocrinology, 50: 28-52

• Spindelegger C, Willeit M, Praschak-Rieder N, Lanzenberger R, Kasper S (2014) Neuroimaging in seasons and winter depression. In: Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, den Boer JA (eds.), PET and SPECT in Psychiatry. Vol. 1. Berlin-Heidelberg-New York: Springer Verlag: pp. 209-222

• Sladky R, Baldinger P, Kranz G, Tröstl J, Höflich A, Lanzenberger R, Moser E, Windischberger C (2013) High-resolution functional MRI of the human amygdala at 7T Eur J Radiol, 82 (5): 728-733
• Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R (2013) Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET Mol Psychiatry, 18 (1): 93-100
• Derntl B, Schopf V, Kollndorfer K, Lanzenberger R (2013) Menstrual Cycle Phase and Duration of Oral Contraception Intake Affect Olfactory Perception Chem Senses, 38 (1): 67-75
• Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R (2013) Impact of electroconvulsive therapy on 5-HT1A receptor binding in major depression Mol Psychiatry, 18 (1): 1-1
• Kalcher K, Boubela R, Huf W, Biswal B, Baldinger P, Sailer U, Filzmoser P, Kasper S, Lamm C, Lanzenberger R, Moser E, Windischberger C (2013) RESCALE: Voxel-specific task-fMRI scaling using resting state fluctuation amplitude Neuroimage, 70: 80-88
• Hahn A, Nics L, Baldinger P, Wadsak W, Savli M, Kraus C, Birkfellner W, Ungersboeck J, Haeusler D, Mitterhauser M, Karanikas G, Kasper S, Frey R, Lanzenberger R (2013) Application of image-derived and venous input functions in major depression using [carbonyl-11C]WAY-100635 Nucl Med Biol, 40 (3): 371-377
• Höflich A, Savli M, Comasco E, Moser U, Novak K, Kasper S, Lanzenberger R (2013) Neuropsychiatric deep brain stimulation for translational neuroimaging Neuroimage, 79: 30-41
• Hahn A, Kranz G, Seidel E, Sladky R, Kraus C, Küblböck M, Pfabigan D, Hummer A, Grahl A, Ganger S, Windischberger C, Lamm C, Lanzenberger R (2013) Comparing neural response to painful electrical stimulation with functional MRI at 3 and 7T Neuroimage, 82: 336-343
• Baldinger P, Hahn A, Mitterhauser M, Kranz G, Friedl M, Wadsak W, Kraus C, Ungersböck J, Hartmann A, Giegling I, Rujescu D, Kasper S, Lanzenberger R (2013) Impact of COMT genotype on serotonin-1A receptor binding investigated with PET Brain Struct Funct, 219 (6): 2017-2028
• Rami-Mark C, Ungersboeck J, Haeusler D, Nics L, Philippe C, Mitterhauser M, Willeit M, Lanzenberger R, Karanikas G, Wadsak W (2013) Reliable set-up for in-loop 11C-carboxylations using Grignard reactions for the preparation of [carbonyl-11C]WAY-100635 and [11C]-(+)-PHNO Appl Radiat Isot, 82: 75-80
• Rami-Mark C, Zhang M, Mitterhauser M, Lanzenberger R, Hacker M, Wadsak W (2013) [18F]FMeNER-D2: Reliable fully-automated synthesis for visualization of the norepinephrine transporter Nucl Med Biol, 40 (8): 1049-1054
• Philippe C, Nics L, Zeilinger M, Schirmer E, Spreitzer H, Karanikas G, Lanzenberger R, Viernstein H, Wadsak W, Mitterhauser M. (2013) Preparation and First Preclinical Evaluation of [18F]FE@SNAP: A Potential PET Tracer for the Melanin Concentrating Hormone Receptor 1 (MCHR1) Sci Pharm, 81 (3): 625-639
• Sladky R, Hoflich A, Kublbock M, Kraus C, Baldinger P, Moser E, Lanzenberger R, Windischberger C (2013) Disrupted Effective Connectivity Between the Amygdala and Orbitofrontal Cortex in Social Anxiety Disorder During Emotion Discrimination Revealed by Dynamic Causal Modeling for fMRI Cereb. Cortex,
• Mark C, Bornatowicz B, Mitterhauser M, Hendl M, Nics L, Haeusler D, Lanzenberger R, Berger ML, Spreizer H, Wadsak W (2013) Development and automation of a novel NET-PET tracer: [11C]Me@APPI Nucl Med and Biol, 40: 295-303

• Baldinger P, Kranz G, Höflich A, Savli M, Stein P, Lanzenberger R, Kasper S (2013) Hormonersatztherapie und deren Wirkung auf Psyche und Gehirn Nervenarzt, 84 (1): 14-19
• Höfer P, Lanzenberger R, Kasper S (2013) Testosterone in the brain: Neuroimaging findings and the potential role for neuropsychopharmacology Eur Neuropsychopharmacol, 23 (2): 79-88
• Dold M, Aigner M, Lanzenberger R, Kasper S (2013) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials Int. J. Neuropsychopharmacol., 16 (3): 557-574
• Vyas NS, Patel NH, Herscovitch P, Puri BK, Lanzenberger R (2013) Recent developments in neurochemical imaging in schizophrenia: an update. Curr Med Chem, : 351-6

• Baldinger P, Hahn A, Friedl M, Kranz GS, Ungersböck J, Höflich A, Mitterhauser M, Rujescu D, Wadsak W, Lanzenberger R, Kasper S (2012) Einfluss der HTR1A-Polymorphismus rs878567 auf das Serotonin-1A-Bindungspotenzial in vivo Journal für Neurologie, Neurochirurgie und Psychiatrie, 13(1): 36-38
• Spindelegger C, Stein P, Wadsak W, Fink M, Mitterhauser M, Moser U, Savli M, Mien L, Akimova E, Hahn A, Willeit M, Kletter K, Kasper S, Lanzenberger R (2012) Light-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain World J Biol Psychiat, 13 (6): 413-422
• Hahn A, Wadsak W, Windischberger C, Baldinger P, Hoflich A, Losak J, Nics L, Philippe C, Kranz G, Kraus C, Mitterhauser M, Karanikas G, Kasper S, Lanzenberger R (2012) Differential modulation of the default mode network via serotonin-1A receptors PNAS, 109 (7): 2619-2624
• Hahn A, Nics L, Baldinger P, Ungersböck J, Dolliner P, Frey R, Birkfellner W, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R (2012) Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling Neuroimage, 62 (1): 199-206
• Ungersboeck J, Richter S, Collier L, Mitterhauser M, Karanikas G, Lanzenberger R, Dudczak R, Wadsak W (2012) Radiolabeling of [18F]altanserin - a microfluidic approach Nucl Med Biol, 39 (7): 1087-1092
• Kranz G, Hahn A, Savli M, Lanzenberger R (2012) Challenges in the differentiation of midbrain raphe nuclei in neuroimaging research PNAS, 109 (29): E2000
• Riederer F, Marti M, Luechinger R, Lanzenberger R, von Meyenburg J, Gantenbein A, Pirrotta R, Gaul C, Kollias S, Sándor P (2012) Grey matter changes associated with medication-overuse headache: Correlations with disease related disability and anxiety World J Biol Psychiat, 13 (7): 517-525
• Savli M, Bauer A, Mitterhauser M, Ding Y, Hahn A, Kroll T, Neumeister A, Haeusler D, Ungersboeck J, Henry S, Isfahani S, Rattay F, Wadsak W, Kasper S, Lanzenberger R (2012) Normative database of the serotonergic system in healthy subjects using multi-tracer PET Neuroimage, 63 (1): 447-459
• Lanzenberger R, Kranz G, Haeusler D, Akimova E, Savli M, Hahn A, Mitterhauser M, Spindelegger C, Philippe C, Fink M, Wadsak W, Karanikas G, Kasper S (2012) Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas Neuroimage, 63 (2): 874-881
• Kraus C, Hahn A, Savli M, Kranz G, Baldinger P, Höflich A, Spindelegger C, Ungersboeck J, Haeusler D, Mitterhauser M, Windischberger C, Wadsak W, Kasper S, Lanzenberger R (2012) Serotonin-1A receptor binding is positively associated with gray matter volume — A multimodal neuroimaging study combining PET and structural MRI Neuroimage, 63 (3): 1091-1098
• Philippe C, Ungersboeck J, Schirmer E, Zdravkovic M, Nics L, Zeilinger M, Shanab K, Lanzenberger R, Karanikas G, Spreitzer H, Viernstein H, Mitterhauser M, Wadsak W (2012) [¹⁸F]FE@SNAP-A new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): microfluidic and vessel-based approaches. Bioorg Med Chem, : 5936–5940
• Philippe C, Schirmer E, Mitterhauser M, Shanab K, Lanzenberger R, Karanikas G, Spreitzer H, Viernstein H, Wadsak W (2012) Radiosynthesis of [11C]SNAP-7941—the first PET-tracer for the melanin concentrating hormone receptor 1 (MCHR1) Appl Radiat Isot, 70 (10): 2287-2294
• Ungersboeck J, Philippe C, Haeusler D, Mitterhauser M, Lanzenberger R, Dudczak R, Wadsak W (2012) Optimization of [11C]DASB-synthesis: Vessel-based and flow-through microreactor methods Appl Radiat Isot, 70 (11): 2615-2620
• Nics L, Hahn A, Zeilinger M, Vraka C, Ungersboeck J, Haeusler D, Hartmann S, Wagner K, Lanzenberger R, Wadsak W, Mitterhauser M (2012) Quantification of the radio-metabolites of the serotonin-1A receptor radioligand [carbonyl-11C]WAY-100635 in human plasma: An HPLC-assay which enables measurement of two patients in parallel Appl Radiat Isot, 70 (12): 2730-2736
• Sladky R, Höflich A, Atanelov J, Kraus C, Baldinger P, Moser E, Lanzenberger R, Windischberger C (2012) Increased Neural Habituation in the Amygdala and Orbitofrontal Cortex in Social Anxiety Disorder Revealed by fMRI PLoS One, 7 (11): e50050

• Stein P, Lanzenberger R, Kasper S, Aigner M (2012) Psychiatrische Manifestation einer milden Form der limbischen Encephalitis. Journal für Neurologie, Neurochirurgie und Psychiatrie, 13(1): 31-34
• Saulin A, Savli M, Lanzenberger R (2012) Serotonin and molecular neuroimaging in humans using PET Amino Acids, 42 (6): 2039-2057
• Höflich A, Baldinger P, Savli M, Lanzenberger R, Kasper S (2012) Imaging treatment effects in depression Rev Neurosci, 23 (3)

• Schöpf V, Windischberger C, Robinson S, Kasess C, Fischmeister F, Lanzenberger R, Albrecht J, Kleemann A, Kopietz R, Wiesmann M, Moser E (2011) Model-free fMRI group analysis using FENICA Neuroimage, 55 (1): 185-193
• Hahn A, Stein P, Windischberger C, Weissenbacher A, Spindelegger C, Moser E, Kasper S, Lanzenberger R (2011) Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder Neuroimage, 56 (3): 881-889
• Ungersboeck J, Philippe C, Mien L, Haeusler D, Shanab K, Lanzenberger R, Spreitzer H, Keppler B, Dudczak R, Kletter K, Mitterhauser M, Wadsak W (2011) Microfluidic preparation of [18F]FE@SUPPY and [18F]FE@SUPPY:2 - comparison with conventional radiosyntheses Nucl Med Biol, 38 (3): 427-434
• Lanzenberger R, Mitterhauser M, Kranz G, Spindelegger C, Wadsak W, Stein P, Moser U, Savli M, Kletter K, Kasper S (2011) Progesterone Level Predicts Serotonin-1A Receptor Binding in the Male Human Brain Neuroendocrinology, 94 (1): 84-88

• Fink M, Moser U, Akimova E, Savli M, Lanzenberger R, Kasper S (2011) ) Multimodale Bildgebung bei einer organischen depressiven Störung mittels fMRT und PET Journal für Neurologie, Neurochirurgie und Psychiatrie, 12(2): 180-182
• Dold M, Aigner M, Lanzenberger R, Kasper S (2011) Effektivität einer Augmentationstherapie mit Antipsychotika bei therapieresistenten Zwangsstörungen – eine Metaanalyse doppelblinder, randomisierter, placebokontrollierter Studien Fortschr Neurol Psychiatr, 79 (08): 453-466

• Assem-Hilger E, Lanzenberger R, Savli M, Wadsak W, Mitterhauser M, Mien LK, Stögmann E, Baumgartner C, Kletter K, Asenbaum S (2010) Central serotonin 1A receptor binding in temporal lobe epilepsy: a [carbonyl-(11)C]WAY-100635 PET study Epilepsy Behav, 19(3): 467-73
• Witte A, Savli M, Holik A, Kasper S, Lanzenberger R (2010) Regional sex differences in grey matter volume are associated with sex hormones in the young adult human brain Neuroimage, 49 (2): 1205-1212
• Windischberger C, Lanzenberger R, Holik A, Spindelegger C, Stein P, Moser U, Gerstl F, Fink M, Moser E, Kasper S (2010) Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: A randomized cross-over study Neuroimage, 49 (2): 1161-1170
• Moser U, Wadsak W, Spindelegger C, Mitterhauser M, Mien L, Bieglmayer C, Kletter K, Kasper S, Lanzenberger R (2010) Hypothalamic serotonin-1A receptor binding measured by PET predicts the plasma level of dehydroepiandrosterone sulfate in healthy women Neurosci Lett, 476 (3): 161-165
• Haeusler D, Nics L, Viernstein H, Wagner K, Dudcz L, Mien L, Ungersboeck J, Lanzenberger R, Shanab K, Sindelar K, Vieak R, Kletter K, Wadsak W, Mitterhauser M (2010) [18F]FE@SUPPY and [18F]FE@SUPPY:2 — metabolic considerations Nucl Med Biol, 37 (4): 421-426
• Lanzenberger R, Wadsak W, Spindelegger C, Mitterhauser M, Akimova E, Mien L, Fink M, Moser U, Savli M, Kranz G, Hahn A, Kletter K, Kasper S (2010) Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions Int J Neuropsychopharmacol, 13 (9): 1129-1143
• Schöpf V, Windischberger C, Kasess C, Lanzenberger R, Moser E (2010) Group ICA of resting-state data: a comparison MAGMA, 23 (5-6): 317-325
• Schöpf V, Kasess C, Lanzenberger R, Fischmeister F, Windischberger C, Moser E (2010) Fully exploratory network ICA (FENICA) on resting-state fMRI data J. Neurosci. Methods, 192 (2): 207-213
• Assem-Hilger E, Lanzenberger R, Savli M, Wadsak W, Mitterhauser M, Mien L, Stogmann E, Baumgartner C, Kletter K, Asenbaum S (2010) Central serotonin 1A receptor binding in temporal lobe epilepsy: A [carbonyl-11C]WAY-100635 PET study Epilepsy Behav, 19 (3): 467-473
• Hahn A, Lanzenberger R, Wadsak W, Spindelegger C, Moser U, Mien L, Mitterhauser M, Kasper S (2010) Escitalopram Enhances the Association of Serotonin-1A Autoreceptors to Heteroreceptors in Anxiety Disorders J Neurosci, 30 (43): 14482-14489

• Kranz G, Kasper S, Lanzenberger R (2010) Reward and the serotonergic system Neuroscience, 166 (4): 1023-1035

• Haeusler D, Mitterhauser M, Mien LK, Shanab K, Lanzenberger R, Schirmer E, Ungersboeck J, Nics L, Spreitzer H, Viernstein H, Dudczak R, Kletter K, Wadsak W. (2009) Radiosynthesis of a novel potential adenosine A3 receptor ligand, 5-ethyl 2,4-diethyl-3-((2-[18F]fluoroethyl)sulfanylcarbonyl)-6-phenylpyridine-5-carboxylate ([18F]FE@SUPPY:2) Radiochim Acta, 97: 753-8
• Spindelegger C, Lanzenberger R, Wadsak W, Mien L, Stein P, Mitterhauser M, Moser U, Holik A, Pezawas L, Kletter K, Kasper S (2009) Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders Mol Psychiatry, 14 (11): 1040-1050
• Witte A, Flöel A, Stein P, Savli M, Mien L, Wadsak W, Spindelegger C, Moser U, Fink M, Hahn A, Mitterhauser M, Kletter K, Kasper S, Lanzenberger R (2009) Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects Human Brain Mapping, 30 (8): 2558-2570
• Fink M, Wadsak W, Savli M, Stein P, Moser U, Hahn A, Mien L, Kletter K, Mitterhauser M, Kasper S, Lanzenberger R (2009) Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET Neuroimage, 45 (2): 598-605
• Haeusler D, Mien L, Nics L, Ungersboeck J, Philippe C, Lanzenberger R, Kletter K, Dudczak R, Mitterhauser M, Wadsak W (2009) Simple and rapid preparation of [11C]DASB with high quality and reliability for routine applications Appl Radiat Isot, 67 (9): 1654-1660
• Weissenbacher A, Kasess C, Gerstl F, Lanzenberger R, Moser E, Windischberger C (2009) Correlations and anticorrelations in resting-state functional connectivity MRI: A quantitative comparison of preprocessing strategies Neuroimage, 47 (4): 1408-1416

• Fink M, Akimova E, Spindelegger C, Hahn A, Lanzenberger R, Kasper S. (2009) Social anxiety disorder: epidemiology, biology and treatment. Psychiatr Danub., 21(4): 533-42
• Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R, Spindelegger C, Asenbaum S, Holik A, Dudczak R (2009) Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram Int Clin Psychopharmacol, 24 (3): 119-125
• Akimova E, Lanzenberger R, Kasper S (2009) The Serotonin-1A Receptor in Anxiety Disorders Biol Psychiatry, 66 (7): 627-635

• Kasper S, Akimova E, Fink M, Lanzenberger R (2009) Maintenance pharmacotherapy in schizophrenia. In: Kasper S, Papadimitriou G (eds.), Schizophrenia: Biopsychosocial Approaches and Current Challenges. 2nd edition. London: Informa Healthcare: pp. 174-184

• Stein P, Savli M, Wadsak W, Mitterhauser M, Fink M, Spindelegger C, Mien L, Moser U, Dudczak R, Kletter K, Kasper S, Lanzenberger R (2008) The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635 Eur J Nucl Med Mol Imaging, 35 (12): 2159-2168
• Wadsak W, Mien LK, Shanab K, Ettlinger DE, Haeusler D, Sindelar K, Lanzenberger R, Spreitzer H, Viernstein H, Keppler BK, Dudczak R, Kletter K, Mitterhauser M. (2008) Preparation and first evaluation of [(18)F]FE@SUPPY: a new PET tracer for the adenosine A(3) receptor. Nucl Med and Biol, 35(1): 61-6
• Windischberger C, Cunnington R, Lamm C, Lanzenberger R, Langenberger H, Deecke L, Bauer H, Moser E (2008) Time-resolved analysis of fMRI signal changes using Brain Activation Movies J. Neurosci. Methods, 169 (1): 222-230
• Kasess C, Windischberger C, Cunnington R, Lanzenberger R, Pezawas L, Moser E (2008) The suppressive influence of SMA on M1 in motor imagery revealed by fMRI and dynamic causal modeling Neuroimage, 40 (2): 828-837
• Gerstl F, Windischberger C, Mitterhauser M, Wadsak W, Holik A, Kletter K, Moser E, Kasper S, Lanzenberger R (2008) Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET Neuroimage, 41 (2): 204-211
• Riederer F, Lanzenberger R, Kaya M, Prayer D, Serles W, Baumgartner C (2008) Network atrophy in temporal lobe epilepsy: A voxel-based morphometry study Neurology, 71 (6): 419-425

• Wadsak W, Mien LK, Ettlinger DE, Feitscher S, Lanzenberger R, Marton J, Dudczak R, Kletter K, Mitterhauser M (2007) Preparation and radiosynthesis of [18F]FE@CFN (2-[18F]fluoroethyl 4-[N-(1- oxopropyl)-N-phenylamino]-1-(2-phenylethyl)-4-piperidinecarboxylate): a potential µ- opioid receptor imaging agent. Radiochim Acta, 95: 33-8
• Wadsak W, Mien LK, Ettlinger DE, Lanzenberger R, Haeusler D, Dudczak R, Kletter K, Mitterhauser M (2007) Simple and fully automated preparation of [carbonyl-11C]WAY-100635. Radiochim Acta, 95: 417-22
• Attarbaschi T, Sacher J, Geiss-Granadia T, Klein N, Mossaheb N, Lanzenberger R, Asenbaum S, Dudczak R, Kasper S, Tauscher J (2007) Striatal D2 receptor occupancy in bipolar patients treated with olanzapine Eur Neuropsychopharmacol, 17 (2): 102-107
• Klein N, Sacher J, Geiss-Granadia T, Mossaheb N, Attarbaschi T, Lanzenberger R, Spindelegger C, Holik A, Asenbaum S, Dudczak R, Tauscher J, Kasper S (2007) Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study Psychopharmycol, 191 (2): 333-339
• Sacher J, Asenbaum S, Klein N, Geiss-Granadia T, Mossaheb N, Poetzi C, Attarbaschi T, Lanzenberger R, Spindelegger C, Rabas A, Heinze G, Dudczak R, Kasper S, Tauscher J (2007) Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand Int J Neuropsychopharmacol, 10 (02): 211
• Lanzenberger R, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien L, Holik A, Attarbaschi T, Mossaheb N, Sacher J, Geiss-Granadia T, Kletter K, Kasper S, Tauscher J (2007) Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder Biol Psychiatry, 61 (9): 1081-1089
• Lanzenberger R, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK, Holik A, Attarbaschi T, Mossaheb N, Sacher J, Geiss-Granadia T, Kletter K, Kasper S, Tauscher J. (2007) Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder. Biol Psychiatry, 61(9): 1081-9
• Mitterhauser M, Toegel S, Wadsak W, Lanzenberger R, Mien LK, Kuntner C, Wanek T, Eidherr H, Ettlinger DE, Viernstein H, Kluger R, Dudczak R, Kletter K. (2007) Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP Nucl Med and Biol, 34(4): 391-7

• Klein N, Sacher J, Geiss-Granadia T, Attarbaschi T, Mossaheb N, Lanzenberger R, Pötzi C, Holik A, Spindelegger C, Asenbaum S, Dudczak R, Tauscher J, Kasper S (2006) In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram Psychopharmycol, 188 (3): 263-272
• Bauer M, Langer O, Dal-Bianco P, Karch R, Brunner M, Abrahim A, Lanzenberger R, Hofmann A, Joukhadar C, Carminati P, Ghirardi O, Piovesan P, Forloni G, Corrado ME, Lods N, Dudczak R, Auff E, Kletter K (2006) A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease. Clin Pharmacol Ther, 80(3): 216-27

• Robinson S, Hoheisel B, Windischberger C, Habel U, Lanzenberger R, Moser E (2005) FMRI of the Emotions: Towards an Improved Understanding of Amygdala Function CURR MED IMAGING REV, 1(2): 115-129
• Lanzenberger R, Kasper S (2005) NeuroImaging bei schizophrenen Erkrankungen Fortschr Neurol Psychiatr, 73: 51-59
• Geissler A, Lanzenberger R, Barth M, Tahamtan AR, Milakara D, Gartus A, Beisteiner R. (2005) Influence of fMRI smoothing procedures on replicability of fine scale motor localization. Neuroimage, 24(2): 323-31
• Lanzenberger R, Wiest G, Geissler A, Barth M, Ringl H, Wöber C, Gartus A, Baumgartner C, Beisteiner R. (2005) FMRI reveals functional cortex in a case of inconclusive Wada testing Clin Neurol Neurosurg, 107(2): 147-51
• Roessler K, Donat M, Lanzenberger R, Novak K, Geissler A, Gartus A, Tahamtan AR, Milakara D, Czech T, Barth M, Knosp E, Beisteiner R. (2005) Evaluation of preoperative high magnetic field motor functional MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation and postoperative outcome. J Neurol Neurosurg Psychiatry, 76(8): 1152-7

• Beisteiner R, Gartus A, Erdler M, Mayer D, Lanzenberger R, Deecke L. (2004) Magnetoencephalography indicates finger motor somatotopy Eur J Neurosci, 19(2): 465-72

• Lanzenberger R, Beisteiner R, Prayer D. (2002) Discussion of the Brain Atlas for Functional Imaging (BAFI), W.L. Nowinski, A. Thirunavuukarasuu, D.N. Kennedy Eur J Radiol, 41(3): 255-6

• Beisteiner R, Windischberger C, Lanzenberger R, Edward V, Cunnington R, Erdler M, Gartus A, Streibl B, Moser E, Deecke L. (2001) Finger somatotopy in human motor cortex. Neuroimage, 6 Pt 1 : 1016-26
• Erdler M, Windischberger C, Lanzenberger R, Edward V, Gartus A, Deecke L, Beisteiner R. (2001) Dissociation of supplementary motor area and primary motor cortex in human subjects when comparing index and little finger movements with functional magnetic resonance imaging. Neurosci Lett, 313(1-2): 5-8

• Beisteiner R, Lanzenberger R, Novak K, Edward V, Windischberger C, Erdler M, Cunnington R, Gartus A, Streibl B, Moser E, Czech T, Deecke L. (2000) Improvement of presurgical patient evaluation by generation of functional magnetic resonance risk maps. Neurosci Lett, 290(1): 13-6
• Edward V, Windischberger C, Cunnington R, Erdler M, Lanzenberger R, Mayer D, Endl W, Beisteiner R. (2000) Quantification of fMRI artifact reduction by a novel plaster cast head holder. Human Brain Mapping, 11(3): 207-13